Show simple item record

dc.contributor.authorLucidarme, Jay
dc.contributor.authorGurler, Nezahat
dc.contributor.authorEMİROĞLU, MELİKE
dc.contributor.authorDİNLEYİCİ, ENER ÇAĞRI
dc.contributor.authorKarbuz, Adem
dc.contributor.authorÇELEBİ, SOLMAZ
dc.contributor.authorDevrim, Ilker
dc.contributor.authorGulfidan, Gamze
dc.contributor.authorÖZGÜR GÜNDEŞLİOĞLU, ÖZLEM
dc.contributor.authorYucel, Mihriban
dc.contributor.authorUlusoy, Emel
dc.contributor.authorCENGİZ, ALİ BÜLENT
dc.contributor.authorBELET, NURŞEN
dc.contributor.authorBorrow, Ray
dc.contributor.authorCEYHAN, MEHMET
dc.contributor.authorÖZSÜREKCİ, YASEMİN
dc.contributor.authorOz, Fatma Nur
dc.contributor.authorKurugol, Zafer
dc.contributor.authorCelik, Umit
dc.contributor.authorParlakay, Ashnur Ozkaya
dc.date.accessioned2021-03-03T18:55:35Z
dc.date.available2021-03-03T18:55:35Z
dc.date.issued2020
dc.identifier.citationCEYHAN M., ÖZSÜREKCİ Y., Lucidarme J., Borrow R., Gurler N., EMİROĞLU M., Oz F. N. , Kurugol Z., Celik U., Parlakay A. O. , et al., "Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017", VACCINE, cilt.38, sa.19, ss.3545-3552, 2020
dc.identifier.issn0264-410X
dc.identifier.othervv_1032021
dc.identifier.otherav_51c312a8-dafc-4e70-9184-4058ed3875d2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/58105
dc.identifier.urihttps://doi.org/10.1016/j.vaccine.2020.03.024
dc.description.abstractDiverse Neisseria meningitidis strains belonging to various serogroups and clonal complexes cause epidemic and endemic life-threatening disease worldwide. This study aimed to investigate the genetic diversity of recent invasive meningococci in Turkey with respect to multilocus sequence type (MLST) and also meningococcal serogroup B (MenB) vaccine antigens to enable assessment of potential MenB strain coverage using the genetic Meningococcal Antigen Typing System (gMATS). Fifty-four isolates, representing 37.5% of all pediatric (ages 0-18 years) invasive meningococcal disease cases in Turkey from January 2013 to December 2017, underwent genome sequence analysis. Thirty-six (66.7%) isolates were MenB, 10 (18.5%) were serogroup W (MenW), 4 (7.4%) were serogroup A (MenA), 3 (5.6%) were serogroup Y (MenY) and 1 (1.8%) was serogroup X (MenX). The MenB isolates were diverse with cc35 (19.4%), cc41/44 (19.4%) and cc32 (13.8%) as the most prevalent clonal complexes. The MenW isolates (n = 10) comprised cc11 (n = 5), ST-2754 (cc-unassigned; n = 4) and cc22 (n = 1). gMATS was indicative of high 4CMenB coverage (72.2-79.1%) of Turkish invasive MenB strains from pediatric patients. Strain coverage of several clonal complexes differed from that seen elsewhere in Europe highlighting the importance of performing local assessments and also the use of phenotypic methods, i.e. MATS, where possible. All of the isolates possessed in-frame fhbp alleles and so were potentially covered by MenB-fHbp. Continued surveillance is essential to guide recommendations for current and future vaccines as well as understanding changes in epidemiology. (C) 2020 Elsevier Ltd. All rights reserved.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleCharacterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017
dc.typeMakale
dc.relation.journalVACCINE
dc.contributor.departmentPublic Health England , ,
dc.identifier.volume38
dc.identifier.issue19
dc.identifier.startpage3545
dc.identifier.endpage3552
dc.contributor.firstauthorID2280452


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record